Intravenous Iron for Heart Failure: Where Is the Evidence?

28th Annual Heart Failure 2024: An Update on Therapy

I. Pina

Overview of Iron Deficiency in Heart Failure & Recognizing Iron Defi…

ACHL

M. Vaduganathan

Treatment of Iron Deficiency Across the Heart Failure Spectrum

ACHL

S. Gale

Cardiotoxicity in Breast Cancer – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardio-Oncology: Definitions and Scope

University of Colorado Department of Medicine

L. Kondapalli

AHA 2024 Insights: Considerations in Care of Patients with Cancer: P…

AHA 2024 Insights

Y. Bryce

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

How the Experts Manage: Cardiotoxicity and IO in NSCLC

MI&T Congressi

J. Remon Masip

ACC 2024 Insights: Pearls of Cardio-Oncology Screening and Management

ACC 2024 Insights

J. Johnson

Cardiotoxicity: Anthracyclines

Scripps Health

M. Davis

Cardio-Oncology in Breast Cancer: Treatment Options for Anthracyclin…

Total Health

I. Rhea

Cardiotoxicity in Melanoma – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardiotoxicity in RCC – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

Cardiac Disease in Breast Cancer: Background & Risk Factors

Total Health

I. Rhea

Treatment of Sarcoid

Scripps Health

P. Kim

2023 Update on Cardiac Amyloid

MUSC Cardiology

J. Griffin

Iron Deficiency Cases and Panel Discussions

ACHL

A. Mardis, S. Gale, M. Vaduganathan

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

Przemyslaw Twardowski

2024 Updates on Carcinoid Heart Disease

North American Neuroendocrine Tumor Society

A. Nohria

Cardio-Oncology: Immune Checkpoint Inhibitor Associated Myocarditis

UCLA Health

E. Yang